AbbVie - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

AbbVie shoots for AAN 2020 target readout for Phase II MS trials at current enrolment rate

Source says AbbVie will present data about its Phase II trials of ABT-555 at AAN 2020. AbbVie’s official press office declined to comment on the story.